FDA Clears Abbott’s New FreeStyle Lite Diabetes Test Strips

Abbott Diabetes Care has announced 510(k) clearance of their new FreeStyle Lite blood glucose test strips, designed for use with the company’s existing FreeStyle Lite monitors. The strips improve the safety of at-home blood glucose monitoring by eliminating the possibility of interference from non-glucose sugars in readings, which according to the FDA has resulted in hundreds of cases of insulin overdose due to erroneously high glucose readings.
From the press release:

The new FreeStyle Lite test strips do not use the GDH-PQQ enzyme, which can be affected by common non-glucose sugars. The new FreeStyle Lite test strips use a GDH-FAD enzyme which is unaffected by common non-glucose sugars, such as maltose or galactose, and minimizes the potential for other interference.
The new FreeStyle Lite test strips are compatible with all FreeStyle Lite blood glucose monitoring systems, eliminating the need to switch meters. The FreeStyle Lite strips feature a new, easier-to-use ZipWik design tapered test strip that offers a better blood glucose testing experience. The new strips are designed to ensure faster blood application and to reduce the number of error messages and wasted test strips.

Press release: Abbott Receives FDA Clearance for New, Easier-to-Use FreeStyle Lite® Test Strips…
Product page: FreeStyle Lite® Blood Glucose Monitoring System…